Malaysia secures resin and naphtha supply from China to mitigate shortages, ensuring stable production of critical medical devices amid global challenges
KUALA LUMPUR: The Ministry of Health has confirmed the supply of medical devices in Malaysia remains stable and under control.
This assurance comes despite a global energy crisis affecting the availability of some high-risk imported products.
The ministry said it is closely monitoring the situation with ongoing mitigation measures in place. These efforts aim to ensure the continuity of the nation’s healthcare system.
As a key proactive step, the Medical Device Authority has finalised a strategic agreement with Chinese authorities. The pact will increase the supply of resin and naphtha for local industrial use.
“This initiative aims to stabilise the supply chain and ensure the continued production of critical medical devices in Malaysia,” the ministry stated.
It added that the additional supply will serve as a key catalyst in addressing current raw material shortages.
The agreement followed strategic discussions chaired by the MDA chief executive. He is also the chairman of the Global Harmonisation Working Party.
The talks involved the director of China (Shanghai) Pilot Free Trade Zone Administration and the Deputy Mayor of Pudong New Area.
“The Malaysian government expresses its appreciation to the Chinese government for its strong commitment,” the MOH statement added.
This commitment supports the stability of raw material supply chains for the regional medical device industry.
The ministry said it will continue to monitor developments closely. This is to ensure the efficient and prudent distribution of medical supplies based on clinical needs.
